Cargando…
Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes
We assessed the frequency of programmed death-ligand 1 (PD-L1) expression by immunohistochemistry (IHC) in a cohort of 522 sarcomas from 457 patients, incuding a subset of 46 patients with 63 matched samples from local recurrence or metastases with primary tumours and/or metachronous metastases. We...
Autores principales: | Vargas, Ana Cristina, Maclean, Fiona M., Sioson, Loretta, Tran, Dinh, Bonar, Fiona, Mahar, Annabelle, Cheah, Alison L., Russell, Peter, Grimison, Peter, Richardson, Louise, Gill, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159201/ https://www.ncbi.nlm.nih.gov/pubmed/32294103 http://dx.doi.org/10.1371/journal.pone.0222551 |
Ejemplares similares
-
Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease
por: Vargas, Ana Cristina, et al.
Publicado: (2021) -
Systemic treatments and outcomes in
CIC
‐rearranged Sarcoma: A national multi‐centre clinicopathological series and literature review
por: Connolly, Elizabeth A., et al.
Publicado: (2022) -
PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma
por: Scheinberg, Tahlia, et al.
Publicado: (2020) -
Quantitative proteomic studies addressing unmet clinical needs in sarcoma
por: Connolly, Elizabeth A., et al.
Publicado: (2023) -
The immune subtypes and landscape of sarcomas
por: Weng, Weiwei, et al.
Publicado: (2022)